- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRTX
Recent news which mentions MRTX
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
From Benzinga
From Benzinga
3 Resilient Stocks with Massive Potential to Boost Your Wealth
November 26, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
From Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
From InvestorPlace
3 No-Brainer Stocks to Buy With $500 Right Now
November 08, 2023
From Motley Fool
What 11 Analyst Ratings Have To Say About Mirati Therapeutics
November 07, 2023
Tickers
MRTX
From Benzinga
From Benzinga
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
October 19, 2023
From InvestorPlace
Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings
October 19, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
October 10, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 09, 2023
From Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
From Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
October 09, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
October 09, 2023
From Benzinga
Bristol Myers Squibb Strengthens Oncology Portfolio With Mirati Therapeutics' $5B Deal
October 09, 2023
From Benzinga
S&P 500, Nasdaq Set For Bleak Start To Week As Middle East Tensions Dampen Risk-On Mood: Earnings, Inflation Data In Focus
October 09, 2023
From Benzinga
From $150 oil to no impact at all: What the surprise attack on Israel means to markets
October 09, 2023
From MarketWatch
Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 09, 2023
From Benzinga
Shares in weapons makers Lockheed Martin, RTX surge following surprise attack on Israel and other stocks on the move
October 09, 2023
From MarketWatch
From MarketWatch
Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts
October 06, 2023
From Benzinga
What's Going On With Mirati Therapeutics Stock?
October 06, 2023
From Benzinga
From Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
August 19, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
From Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
August 09, 2023
From Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.